G-BA requested RWE collection for the second time – Fedratinib in myelofibrosis
Since 2020, the G-BA can request real-world evidence data collection in Germany. However, so far this was only implemented for one product,
German Market Access – Simplified
Everything you need to know in one place, explained in simple terms
Since 2020, the G-BA can request real-world evidence data collection in Germany. However, so far this was only implemented for one product,
On Friday, 21 Oct 2022, the German House of Representatives has now finalized the law on the financial stabilization of statutory health
In September 2022, the University of Hamburg published its study on the effects of the G-DRG system. Hospital treatments in Germany are
Serious medical device shortages in Germany have been observed – and more are expected – as a consequence of the new EU
Since 2020, clinicians can prescribe – and SHI funds will reimburse – medical apps and digital health treatments, the so-called “DiGAs”. The BfArM assesses these DiGAs